EWASdb: epigenome-wide association study database

       EWASdb : epigenome-wide association study database


EWAS for single marker      EWAS for KEGG Pathway      EWAS for GO Category      Browers by class      Browers by alph      FAQ

The data is big,please wait a moment......

Search Result for GO Categories

Total 1094 records 93/110 page first << upPage 9192 939495 downPage >> last

EWAS ID GO ID Class Disease/Phenotype
[sample size n]
Sample groups
(case/control, trait, cell type etc.)
Categories GO Term Name GO Term Gene Number Gene Number Annotated In The GO Term Pvalue
Group1
[sample size n]
Group2
[sample size n]
EWAS1296 GO:0050670 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process regulation of lymphocyte proliferation 106 86 0.000986
EWAS1296 GO:0050671 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process positive regulation of lymphocyte proliferation 75 63 0.000586
EWAS1296 GO:0050673 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process epithelial cell proliferation 167 132 0.000685
EWAS1296 GO:0050714 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process positive regulation of protein secretion 48 42 0.000521
EWAS1296 GO:0050727 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process regulation of inflammatory response 105 86 0.000534
EWAS1296 GO:0050729 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process positive regulation of inflammatory response 47 43 0.000030
EWAS1296 GO:0050730 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process regulation of peptidyl-tyrosine phosphorylation 84 72 0.000067
EWAS1296 GO:0050731 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process positive regulation of peptidyl-tyrosine phosphorylation 66 57 0.000192
EWAS1296 GO:0050764 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process regulation of phagocytosis 22 21 0.000223
EWAS1296 GO:0050766 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
biological_process positive regulation of phagocytosis 17 17 0.000000

Total 1094 records 93/110 page first << upPage 9192 939495 downPage >> last